AtriCure (NASDAQ:ATRC – Free Report) had its target price decreased by JPMorgan Chase & Co. from $51.00 to $46.00 in a ...
AtriCure, Inc. (NASDAQ:ATRC – Get Free Report) dropped 6.8% during mid-day trading on Friday after Canaccord Genuity Group lowered their price target on the stock from $66.00 to $52.00.
Hosted on MSN1mon
AtriCure (ATRC) Upgraded to Buy: Here's What You Should KnowInvestors might want to bet on AtriCure (ATRC), as it has been recently upgraded ... which is one of the most powerful forces impacting stock prices. The sole determinant of the Zacks rating ...
BTIG raised the firm’s price target on AtriCure (ATRC) to $58 from $57 and keeps a Buy rating on the shares after the company’s Investor Day.
Karen Prange, a director at $ATRC, sold 6,100 shares of the company on 03-05-2025 for an estimated $232,531. We received data on the trade from a recent SEC filing ...
AtriCure (ATRC) delivered earnings and revenue surprises of 46.67% and 0.01%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Across the recent three months, 11 analysts have shared their insights on AtriCure ATRC, expressing a variety ... 150 analyst firms and reports on their stock expectations. Analysts typically ...
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback